BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32247519)

  • 1. Analysis of the nuclear expression of pSer727-STAT3 as a prognostic factor in patients with clear cell renal carcinoma.
    Lorente D; Arevalo J; Salcedo MT; Trilla E; de Torres I; Meseguer A; Morote J
    Actas Urol Esp (Engl Ed); 2020 May; 44(4):245-250. PubMed ID: 32247519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC).
    Arévalo J; Lorente D; Trilla E; Salcedo MT; Morote J; Meseguer A
    Sci Rep; 2021 Mar; 11(1):6957. PubMed ID: 33772065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
    Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
    Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
    Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
    World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
    Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
    Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of STAT3 protein as a prognostic factor in the clear cell renal carcinoma. Systematic review.
    Lorente D; Trilla E; Meseguer A; Arevalo J; Nemours S; Planas J; Placer J; Celma A; Salvador C; Regis L; Schwartzmann I; Morote J
    Actas Urol Esp (Engl Ed); 2019 Apr; 43(3):118-123. PubMed ID: 30466966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.
    Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E
    Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.
    Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
    Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
    Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
    Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
    Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
    Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
    Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
    Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.
    NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J
    Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.